Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
interstitial lung diseases
MeSH D017563 - interstitial lung diseases
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D008171:
Lung diseases
3 Companies
2 Drugs
$
Success rate
D017563:
Interstitial lung diseases
0 Companies
0 Drugs
Success rate
D000542:
Extrinsic allergic alveolitis
0 Companies
0 Drugs
Success rate
D006646:
Langerhans-cell histiocytosis
3 Companies
1 Drug
$
Success rate
D011009:
Pneumoconiosis
0 Companies
0 Drugs
Success rate
D011658:
Pulmonary fibrosis
17 Companies
1 Drug
$
Success rate
D014890:
Granulomatosis with polyangiitis
23 Companies
3 Drugs
$
Success rate
D017564:
Radiation pneumonitis
0 Companies
0 Drugs
Success rate
D017565:
Pulmonary sarcoidosis
0 Companies
0 Drugs
Success rate
D019867:
Anti-glomerular basement membrane disease
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
25
%
1/4
Phase 2
49
%
20/41
Phase 3
32
%
6/19
Approved:
0
Overall Success rate:
4%
All Clinical Trials
No data
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use